Decreased Periprosthetic Bone Loss in Patients Treated with Clodronate: A 1-Year Randomized Controlled Study

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Calcified Tissue International

• Publication date

  2010-04-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00223-010-9356-1PMID 20390409
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Risedronate reduces postoperative bone resorption after cementless total hip arthroplasty

  2007influential reference
• Aseptic loosening, not only a question of wear: A review of different theories

  2006cited by this paper
• Clodronate Reduces the Incidence of Fractures in Community‐Dwelling Elderly Women Unselected for Osteoporosis: Results of a Double‐Blind, Placebo‐Controlled Randomized Study

  2006cited by this paper
• Changes of the biochemical markers of bone turnover and periprosthetic bone remodeling after cemented hip arthroplasty.

  2006influential reference
• Postoperative clodronate decreases prosthetic migration: 4–year follow-up of a randomized radiostereometric study of 50 total knee patients

  2006cited by this paper
• Alendronate prevents femoral periprosthetic bone loss following total hip arthroplasty: Prospective randomized double‐blind study

  2006cited by this paper
• Effect of pamidronate on bone turnover and implant migration after total hip arthroplasty: A randomized trial

  2005influential reference
• Etidronate does not suppress periprosthetic bone loss following cemented hip arthroplasty

  2005influential reference
• Effect of bisphosphonates on periprosthetic bone mineral density after total joint arthroplasty. A meta-analysis.

  2005cited by this paper
• Changes in bone mineral density in the proximal femur after cementless total hip arthroplasty. A five-year longitudinal study.

  2004cited by this paper
• Clodronate Reduces Vertebral Fracture Risk in Women With Postmenopausal or Secondary Osteoporosis: Results of a Double‐Blind, Placebo‐Controlled 3‐Year Study

  2004cited by this paper
• Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss

  2004cited by this paper
• Sequential changes in periprosthetic bone mineral density following total hip arthroplasty: a 3-year follow-up

  2003cited by this paper
• Predictive value of a preoperative biochemical bone marker in relation to bone remodeling after cementless total hip arthroplasty.

  2003cited by this paper
• Pattern of Periprosthetic Bone Remodeling Around Stable Uncemented Tapered Hip Stems: A prospective 84-month follow-up study and a Median 156-month Cross-Sectional Study with DXA

  2003cited by this paper
• Cyclic therapy with etidronate has a therapeutic effect against local osteoporosis after cementless total hip arthroplasty.

  2003cited by this paper
• Complications in primary total hip arthroplasty: avoidance and management: wear.

  2003cited by this paper
• Effects upon Bone Metabolism following Total Hip and Total Knee Arthroplasty

  2002influential reference
• Alendronate Reduces Periprosthetic Bone Loss After Uncemented Primary Total Hip Arthroplasty: A Prospective Randomized Study

  2001cited by this paper
• Effect of Pamidronate in Preventing Local Bone Loss After Total Hip Arthroplasty: A Randomized, Double‐Blind, Controlled Trial

  2001cited by this paper
• Hip disease and the prognosis of total hip replacements. A review of 53,698 primary total hip replacements reported to the Norwegian Arthroplasty Register 1987-99.

  2001cited by this paper
• The osteoclastogenic molecules RANKL and RANK are associated with periprosthetic osteolysis.

  2001cited by this paper
• Wear and periprosthetic osteolysis: the problem.

  2001cited by this paper
• Monitoring of Periprosthetic BMD After Uncemented Total Hip Arthroplasty with Dual‐Energy X‐Ray Absorptiometry—a 3‐Year Follow‐Up Study

  2001cited by this paper
• Analgesic effect of bisphosphonates in mice

  2001cited by this paper
• Contrasting effects of alendronate and clodronate on RAW 264 macrophages: the role of a bisphosphonate metabolite.

  1999cited by this paper
• Intramuscular clodronate therapy in postmenopausal osteoporosis.

  1999cited by this paper
• A cost-effectiveness analysis of total hip arthroplasty for osteoarthritis of the hip.

  1997cited by this paper
• Periprosthetic Bone Density Around Fully Hydroxyapatite Coated Femoral Stem

  1997cited by this paper
• Periprosthetic Bone Loss and Regional Bone Turnover in Uncemented Total Hip Arthroplasty: A Prospective Study Using High Resolution Single Photon Emission Tomography and Dual‐Energy X‐Ray Absorptiometry

  1997cited by this paper
• Periprosthetic bone density in uncemented femoral hip implants with proximal hydroxylapatite coating.

  1996cited by this paper
• A Cost-effectiveness Analysis of Total Hip Arthroplasty for Osteoarthritis of the Hip

  1996cited by this paper
• "Modes of failure" of cemented stem-type femoral components: a radiographic analysis of loosening.

  1979cited by this paper

• Effectiveness of treatments to prevent femoral periprosthetic bone loss following total hip arthroplasty: a network meta-analysis

  2025cites this paper
• Determining the most effective osteoporosis drug for bone mineral density loss in proximal area after total hip arthroplasty: A network meta-analysis

  2025cites this paper
• Comparing the Efficacy of Antiosteoporotic Drugs in Preventing Periprosthetic Bone Loss Following Total Hip Arthroplasty: A Systematic Review and Bayesian Network Meta‐Analysis

  2024cites this paper
• Anti-osteoporotic drug efficacy for periprosthetic bone loss after total hip arthroplasty: A systematic review and network meta-analysis.

  2024cites this paper
• Should patients with periprosthetic fracture around the hip or knee be screened, and treated, for osteoporosis?

  2024cites this paper
• Bisphosphonates’ use and risk of aseptic loosening following total hip arthroplasty: a systematic review

  2023cites this paper
• Enhanced Osteolysis Targeted Therapy through Fusion of Exosomes Derived from M2 Macrophages and Bone Marrow Mesenchymal Stem Cells: Modulating Macrophage Polarization.

  2023cites this paper
• Intra-operative Clodronate Rinsing Improves the Integration of the Femoral Stem in a Prospective, Double-blinded, Randomized, Placebo-controlled Clinical RSA-study

  2021cites this paper
• Osseointegration Pharmacology: A Systematic Mapping Using Artificial Intelligence.

  2020cites this paper
• Use of clodronate for painful knee prosthesis in osteoarthritis patients: a 6 month pilot study.

  2020cites this paper
• Diagnosis and management of implant debris-associated inflammation

  2019cites this paper
• Clodronate improves lameness in horses without changing bone turnover markers

  2018cites this paper
• Bisphosphonates for the preservation of periprosthetic bone mineral density after total joint arthroplasty: a meta-analysis of 25 randomized controlled trials

  2018cites this paper
• Effects of bisphosphonates in preventing periprosthetic bone loss following total hip arthroplasty: a systematic review and meta-analysis

  2018cites this paper
• Clodronate in the management of different musculoskeletal conditions.

  2018cites this paper
• Densitometric evaluation might prevent failure of knee artroplasty for aseptic loosening

  2016cites this paper
• Effect of one-year post-operative alendronate treatment on periprosthetic bone after total knee arthroplasty. A seven-year randomised controlled trial of 26 patients.

  2015cites this paper
• Report: Osteocyte enhancement function of bisphosphonates in prosthetic replacement.

  2015cites this paper
• Effect of bisphosphonates in preventing femoral periprosthetic bone resorption after primary cementless total hip arthroplasty: a meta-analysis

  2015influential citation
• Densitometric evaluation of bone remodelling around Trabecular Metal Primary stem: a 24-month follow-up

  2015cites this paper
• Association of Bisphosphonate Use and Risk of Revision After THA: Outcomes From a US Total Joint Replacement Registry

  2015cites this paper
• Osseointegration of Fitmore stem in total hip arthroplasty.

  2014cites this paper
• Systematic analysis of bisphosphonate intervention on periprosthetic BMD as a function of stem design.

  2014cites this paper
• Influential factors in bisphosphonates for periprosthetic bone loss after total joint arthroplasty

  2014cites this paper
• Densitometric evaluation of periprosthetic bone remodeling.

  2014cites this paper
• Pharmacologic Augmentation of Implant Fixation in Osteopenic Bone

  2014cites this paper
• Are Biologic Treatments a Potential Approach to Wear- and Corrosion-related Problems?

  2014cites this paper
• A meta-analysis of bisphosphonates for periprosthetic bone loss after total joint arthroplasty

  2013influential citation
• Painful prosthesis: approaching the patient with persistent pain following total hip and knee arthroplasty.

  2013cites this paper
• Bisphosphonates for periprosthetic bone loss after joint arthroplasty: a meta-analysis of 14 randomized controlled trials

  2012influential citation